Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
出版年份 2022 全文链接
标题
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 1827-1845
出版商
Informa UK Limited
发表日期
2022-06-15
DOI
10.2147/dddt.s281631
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Givosiran in acute intermittent porphyria: A personalized medicine approach
- (2022) Antoine Poli et al. MOLECULAR GENETICS AND METABOLISM
- siRNA drug Leqvio (inclisiran) to lower cholesterol
- (2022) Julia M. Migliorati et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Nonclinical Pharmacokinetics and ADME of Givosiran, the First Approved GalNAc-conjugated RNAi Therapeutic
- (2021) Jing Li et al. DRUG METABOLISM AND DISPOSITION
- Givosiran: A Review in Acute Hepatic Porphyria
- (2021) Yahiya Y. Syed DRUGS
- Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran
- (2021) Jordi To‐Figueras et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Renal Function Decline With Small Interfering RNA Silencing Aminolevulinic Acid Synthase 1 (ALAS1)
- (2021) Hélène Lazareth et al. Kidney International Reports
- Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
- (2021) Petro E. Petrides et al. ANNALS OF HEMATOLOGY
- A Drug‐Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid (siRNA), on Cytochrome P450 Activity in Liver
- (2021) Daphne Vassiliou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Acute intermittent porphyria, givosiran, and homocysteine
- (2021) Antonio Fontanellas et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta‐synthase
- (2021) Daphne Vassiliou et al. JOURNAL OF INTERNAL MEDICINE
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- S1170 Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 24-Month Interim Analysis of the Phase 3 ENVISION Randomized Clinical Trial
- (2021) Herbert L. Bonkovsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
- (2021) Paolo Ventura et al. LIVER INTERNATIONAL
- Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria
- (2021) Hung-Chou Kuo et al. Frontiers in Pharmacology
- Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria
- (2020) Sagar Agarwal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
- (2020) Peter Kaplan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase 1/2 open label extension study of givosiran, an investigational RNAi therapeutic, in patients with acute intermittent porphyria
- (2020) Penelope Stein et al. JOURNAL OF HEPATOLOGY
- Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
- (2020) Christopher R Brown et al. NUCLEIC ACIDS RESEARCH
- Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP)
- (2020) Samira Massachi et al. JOURNAL OF MEDICAL ECONOMICS
- Liver Transplantation for Acute Intermittent Porphyria
- (2020) Mattias Lissing et al. LIVER TRANSPLANTATION
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heme biosynthesis and the porphyrias
- (2019) John D. Phillips MOLECULAR GENETICS AND METABOLISM
- Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
- (2019) Simoneide S. Titze-de-Almeida et al. Molecular Diagnosis & Therapy
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria
- (2018) Hugo Lenglet et al. HUMAN MOLECULAR GENETICS
- Placental expression of asialoglycoprotein receptor associated with Hepatitis B virus transmission from mother to child
- (2018) Ashish Kumar Vyas et al. LIVER INTERNATIONAL
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Acute hepatic porphyrias: Recommendations for evaluation and long-term management
- (2017) Manisha Balwani et al. HEPATOLOGY
- Porphyria
- (2017) D. Montgomery Bissell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- (2017) K. John Pasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
- (2017) Xiulong Shen et al. NUCLEIC ACIDS RESEARCH
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Acute Intermittent Porphyria: Predicted Pathogenicity ofHMBSVariants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease
- (2016) Brenden Chen et al. HUMAN MUTATION
- Role of Delta-aminolevulinic Acid in the Symptoms of Acute Porphyria
- (2015) D. Montgomery Bissell et al. AMERICAN JOURNAL OF MEDICINE
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
- (2015) Anisha A. D'Souza et al. JOURNAL OF CONTROLLED RELEASE
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Afamelanotide for Erythropoietic Protoporphyria
- (2015) Janneke G. Langendonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
- (2015) Amy Chan et al. Molecular Therapy-Nucleic Acids
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency and Two MTHFR Variants in an Adolescent With Progressive Myoclonic Epilepsy
- (2014) Kristin E. D'Aco et al. PEDIATRIC NEUROLOGY
- RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice
- (2014) M. Yasuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria
- (2009) Eva Innala et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Variegate porphyria induces plasma and neutrophil oxidative stress: effects of dietary supplementation with vitamins E and C
- (2009) Miguel D. Ferrer et al. BRITISH JOURNAL OF NUTRITION
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- VEGF inhibitors for the treatment of neovascular age-related macular degeneration
- (2009) Mark Rami Barakat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- RNAi mechanisms and applications
- (2008) Daniel H. Kim et al. BIOTECHNIQUES
- Case 20-2008
- (2008) Herbert L. Bonkovsky et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now